Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing left bundle branch pacing to standard right ventricular pacing

Official title: LEFT Bundle Pacing vs Standard Right Ventricular Pacing for Heart Failure

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT05015660 · Data updated 2026-11-12

This study tests if a new way of pacing the heart called left bundle branch pacing can help people with a serious heart condition live longer and feel better compared to the standard pacing method.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1300 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedDecember 1, 2026
Study endsJanuary 1, 2030
Registry record updatedMarch 11, 2026
Trial IDNCT05015660 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with an ejection fraction greater than 35% and high-degree AV block requiring more than 90% ventricular pacing.

Probably not a fit

Patients who may not benefit include those with indications for an implantable cardioverter defibrillator or other serious medical conditions with a life expectancy of less than two years.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of left bundle branch pacing (LBBP) compared to standard right ventricular pacing (RVP) in patients with high-degree atrioventricular block. The study aims to determine if LBBP can reduce cardiovascular death, heart failure events, and changes in left ventricular size over time. Patients will undergo echocardiograms and NTproBNP tests at various intervals to monitor their heart function and health outcomes. The trial focuses on individuals who are expected to require significant ventricular pacing due to their heart condition.

Why it matters

Potential benefit: If successful, this approach could lead to improved heart function and reduced cardiovascular risks for patients requiring pacemakers.

How similar studies have gone: While the approach of left bundle branch pacing is emerging, it is still relatively novel and has not been extensively tested in large-scale studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Patients with an ejection fraction of \>35%
3. Patients with an indication for ventricular pacing and high-degree atrioventricular block where the degree of anticipated RV pacing is \>90% including:

   1. Third degree AV block
   2. Symptomatic or asymptomatic second-degree AV block
   3. First degree AV block ≥ 280ms with a narrow QRS, or ≥ 240ms with an intraventricular delay (QRS duration ≥120ms)
4. Echocardiogram within the last 3 months, with ability to have DICOM images

Exclusion Criteria:

1. Indication for an implantable cardioverter defibrillator
2. Presence of a mechanical tricuspid valve
3. Any prior attempt at implantation of an ICD, CRT, HBP, or LBBP
4. Lack of capacity to consent
5. Other serious medical condition with life expectancy of \<2 years
6. Pregnancy
7. Patients in whom the conduction system abnormality is expected to be transient or recover over time
8. Patients with permanent atrial fibrillation

Where it's running

  • McGill University Health Centre-Research Institute
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.